New cancer drug ORB-011 tested in early human trial
Disease control
Completed
This early-stage trial tested an investigational drug called ORB-011 in 55 adults with advanced solid tumors (cancers that have spread or come back). The main goals were to see if the drug is safe and to find the best dose for future studies. Participants received ORB-011 by IV i…
Phase: PHASE1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC